Koyfin Home > Directory > Health Care > Nymox Pharm Corp > Net Debt / EBITDA

Nymox Pharm Corp Net Debt / EBITDA Chart (NYMX)

Nymox Pharm Corp annual/quarterly Net Debt / EBITDA from 2010 to 2020. Net Debt / EBITDA is a measure of leverage for a company by dividing the Debt less Cash on hand vs. EBITDA.
  • Nymox Pharm Corp Net Debt / EBITDA for the quarter ending June 06, 2020 was $0m a -1,201.89% decrease of -1m year over year
  • Nymox Pharm Corp Net Debt / EBITDA for the last 12 months ending June 06, 2020 was $0m a -783.81% decrease of 0m year over year
  • Nymox Pharm Corp Annual Net Debt / EBITDA for 2019 was $0m a -83.46% decrease of 0m from 2018
  • Nymox Pharm Corp Annual Net Debt / EBITDA for 2018 was $1m a 91.39% increase of 1m from 2017
  • Nymox Pharm Corp Annual Net Debt / EBITDA for 2017 was $0m a -31.39% decrease of 0m from 2016
Other Ratios Metrics:
  • Nymox Pharm Corp Total Debt / Capital for the quarter ending September 09, 2017 was $98m a 78.16% increase of 77m year over year
  • Nymox Pharm Corp Other Liabilities for the quarter ending December 12, 2016 was $0m a 208,053.10% decrease of -2m year over year
  • Nymox Pharm Corp Total Debt / Equity for the quarter ending September 09, 2017 was $6,192m a 99.37% increase of 6,153m year over year
View Chart On Koyfin

Quarterly NYMX Net Debt / EBITDA Data

06/2020$0m
03/2020$0m
12/2019$1m
09/2019$1m
06/2019$0m
03/2019$1m
12/2018$1m
09/2018$0m
06/2018$1m
03/2018$0m

Annual NYMX Net Debt / EBITDA Data

2019$0m
2018$1m
2017$0m
2016$0m
2015$0m
2014$0m
2013$0m
2012$0m
2011$1m
2010$2m